Search

Your search keyword '"Kääb Stefan"' showing total 1,217 results

Search Constraints

Start Over You searched for: Author "Kääb Stefan" Remove constraint Author: "Kääb Stefan"
1,217 results on '"Kääb Stefan"'

Search Results

201. Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care

203. Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation

204. Subcutaneous or Transvenous Defibrillator Therapy

205. Rhythmusmonitoring

209. The INFluence of Remote monitoring on Anxiety/depRession, quality of lifE, and Device acceptance in ICD patients: a prospective, randomized, controlled, single-center trial

210. Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure

211. Update on Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation

212. Genome-wide association analysis identifies multiple loci related to resting heart rate

215. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation

217. Chronically elevated branched chain amino acid levels are pro-arrhythmic.

219. Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy : An ¹²³I-metaiodobenzylguanidine SPECT/CT study

220. Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators

221. The influence of prompts on final year medical students' learning process and achievement in ECG interpretation

229. Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation

230. Continued misuse of orphan drug legislation:a life-threatening risk for mexiletine

231. Genetic determinants of electrocardiographic P-wave duration and relation to atrial fibrillation

232. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome

234. Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure.

236. Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial

237. Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI

238. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT)

239. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation

241. Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine

243. Quantitative assessment of cardiac 123iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: Novel insight in disease monitoring.

244. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes

245. Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6

247. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry

248. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data

249. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project

250. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study

Catalog

Books, media, physical & digital resources